TMCI — Treace Medical Concepts Cashflow Statement
0.000.00%
Last trade - 00:00
- $644.13m
- $573.94m
- $187.12m
- 32
- 24
- 39
- 23
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -4.26 | -3.67 | -20.6 | -42.8 | -49.5 |
Depreciation | |||||
Non-Cash Items | 1.11 | 3.28 | 4 | 15.8 | 19.3 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -5.31 | -5.32 | -1.33 | -5.81 | -9.74 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -7.67 | -4.49 | -17.2 | -30.6 | -34.6 |
Capital Expenditures | -1.21 | -1.07 | -2.71 | -14.8 | -11.5 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | — | — | — | -61.7 | -69.8 |
Acquisition of Business | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Cash from Investing Activities | -1.21 | -1.07 | -2.71 | -76.5 | -81.3 |
Financing Cash Flow Items | -0.329 | -0.179 | 0 | -0.989 | -0.013 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 19.7 | 11.5 | 108 | 20.8 | 109 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 10.9 | 5.94 | 87.8 | -86.4 | -6.49 |